Abstract

The purpose of this study was to determine the lifetime burden and risk factors for hospitalization after heart failure (HF) diagnosis in the community. Hospitalizations in patients with HF represent a major public health problem; however, the cumulative burden of hospitalizations after HF diagnosis is unknown, and no consistent risk factors for hospitalization have been identified. We validated a random sample of all incident HF cases in Olmsted County, Minnesota, from 1987 to 2006 and evaluated all hospitalizations after HF diagnosis through 2007. International Classification of Diseases-9th Revision codes were used to determine the primary reason for hospitalization. To account for repeated events, Andersen-Gill models were used to determine the predictors of hospitalization after HF diagnosis. Patients were censored at death or last follow-up. Among 1,077 HF patients (mean age 76.8 years, 582 [54.0%] female), 4,359 hospitalizations occurred over a mean follow-up of 4.7 years. Hospitalizations were common after HF diagnosis, with 895 (83.1%) patients hospitalized at least once, and 721 (66.9%), 577 (53.6%), and 459 (42.6%) hospitalized > or =2, > or =3, and > or =4 times, respectively. The reason for hospitalization was HF in 713 (16.5%) hospitalizations and other cardiovascular in 936 (21.6%), whereas over one-half (n = 2,679, 61.9%) were noncardiovascular. Male sex, diabetes mellitus, chronic obstructive pulmonary disease, anemia, and creatinine clearance <30 ml/min were independent predictors of hospitalization (p < 0.05 for each). Multiple hospitalizations are common after HF diagnosis, though less than one-half are due to cardiovascular causes. Comorbid conditions are strongly associated with hospitalizations, and this information could be used to define effective interventions to prevent hospitalizations in HF patients.

Keywords

MedicineHeart failureIntensive care medicineEmergency medicineMedical emergencyCardiology

MeSH Terms

AgedDiagnostic TechniquesCardiovascularFemaleFollow-Up StudiesHeart FailureHospitalizationHospitalsCommunityHumansIncidenceMaleMinnesotaPrognosisRetrospective Studies

Affiliated Institutions

Related Publications

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

Background Sodium–glucose co‐transporter 2 (SGLT2) inhibitors have been shown to reduce the risk of incident heart failure hospitalization in individuals with type 2 diabetes wh...

2019 European Journal of Heart Failure 430 citations

Publication Info

Year
2009
Type
letter
Volume
54
Issue
18
Pages
1695-1702
Citations
464
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

464
OpenAlex
20
Influential
407
CrossRef

Cite This

Shannon M. Dunlay, Margaret M. Redfield, Susan A. Weston et al. (2009). Hospitalizations After Heart Failure Diagnosis. Journal of the American College of Cardiology , 54 (18) , 1695-1702. https://doi.org/10.1016/j.jacc.2009.08.019

Identifiers

DOI
10.1016/j.jacc.2009.08.019
PMID
19850209
PMCID
PMC2803107

Data Quality

Data completeness: 90%